| HIV-1 infection in an individual homozygous for the CCR5 deletion allele. R Biti, R Ffrench, J Young, B Bennetts, G Stewart, T Liang | 449 | 1997 |
| Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation CE Harvey, JJ Post, P Palladinetti, AJ Freeman, RA Ffrench, RK Kumar, ... Journal of Leucocyte Biology 74 (3), 360-369, 2003 | 312 | 2003 |
| Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort JJ Post, Y Pan, AJ Freeman, CE Harvey, PA White, P Palladinetti, ... Journal of Infectious Diseases 189 (10), 1846-1855, 2004 | 187 | 2004 |
| Immunopathogenesis of hepatitis C virus infection AJ Freeman, G Marinos, RA Ffrench, AR Lloyd Immunology and cell biology 79 (6), 515-536, 2001 | 179 | 2001 |
| The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo JA Tye-Din, RP Anderson, RA Ffrench, GJ Brown, P Hodsman, M Siegel, ... Clinical immunology 134 (3), 289-295, 2010 | 174 | 2010 |
| Immunogenicity of a Human Immunodeficiency Virus (HIV) Polytope Vaccine Containing Multiple HLA A2 HIV CD8+ Cytotoxic T-Cell Epitopes T Woodberry, J Gardner, L Mateo, D Eisen, J Medveczky, IA Ramshaw, ... Journal of virology 73 (7), 5320-5325, 1999 | 156 | 1999 |
| Increased frequency of CCR-5 Δ32 heterozygotes among long-term non-progressors with HIV-1 infection GJ Stewart, LJ Ashton, RA Biti, RA Ffrench, BH Bennetts, NR Newcombe, ... Aids 11 (15), 1833-1838, 1997 | 155 | 1997 |
| Host and viral factors in the immunopathogenesis of primary hepatitis C virus infection AR Lloyd, E Jagger, JJ Post, LA Crooks, WD Rawlinson, YS Hahn, ... Immunology and cell biology 85 (1), 24-32, 2007 | 119 | 2007 |
| Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort S Teutsch, F Luciani, N Scheuer, L McCredie, P Hosseiny, W Rawlinson, ... BMC public health 10, 1-9, 2010 | 108 | 2010 |
| Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load B Cameron, M Bharadwaj, J Burrows, C Fazou, D Wakefield, I Hickie, ... The Journal of infectious diseases 193 (5), 664-671, 2006 | 99 | 2006 |
| The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infection AJ Freeman, Y Pan, CE Harvey, JJ Post, MG Law, PA White, ... Journal of hepatology 38 (3), 349-356, 2003 | 88 | 2003 |
| A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1 AD Kelleher, RL Puls, M Bebbington, D Boyle, R Ffrench, SJ Kent, ... Aids 20 (2), 294-297, 2006 | 81 | 2006 |
| A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals EJ Gowans, S Roberts, K Jones, I Dinatale, PA Latour, B Chua, ... Journal of hepatology 53 (4), 599-607, 2010 | 78 | 2010 |
| Early IL‐10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users JK Flynn, GJ Dore, M Hellard, B Yeung, WD Rawlinson, PA White, ... Journal of Viral Hepatitis 18 (8), 549-561, 2011 | 73 | 2011 |
| Protective immunity against hepatitis C virus infection LN Elliott, AR Lloyd, JB Ziegler, RA Ffrench Immunology and cell biology 84 (3), 239-249, 2006 | 58 | 2006 |
| Prevalence of production of virus-specific interferon-γ among seronegative hepatitis C-resistant subjects reporting injection drug use AJ Freeman, RA Ffrench, JJ Post, CE Harvey, SJ Gilmour, PA White, ... The Journal of infectious diseases 190 (6), 1093-1097, 2004 | 58 | 2004 |
| A phase I study to determine safety, tolerability and bioactivity of Nexvax2® in HLA DQ2+ volunteers with celiac disease following a long-term, strict gluten-free diet GJ Brown, J Daveson, JK Marjason, RA Ffrench, D Smith, M Sullivan, ... Gastroenterology 5 (140), S-437-S-438, 2011 | 56 | 2011 |
| Evaluation in macaques of HIV-1 DNA vaccines containing primate CpG motifs and fowlpoxvirus vaccines co-expressing IFNγ or IL-12 CJ Dale, R De Rose, KM Wilson, HA Croom, S Thomson, BEH Coupar, ... Vaccine 23 (2), 188-197, 2004 | 56 | 2004 |
| Quantification of hepatitis C virus in human liver and serum samples by using LightCycler reverse transcriptase PCR PA White, Y Pan, AJ Freeman, G Marinos, RA Ffrench, AR Lloyd, ... Journal of clinical microbiology 40 (11), 4346-4348, 2002 | 54 | 2002 |
| Development of a synthetic consensus sequence scrambled antigen HIV-1 vaccine designed for global use SA Thomson, AB Jaramillo, M Shoobridge, KJ Dunstan, B Everett, ... Vaccine 23 (38), 4647-4657, 2005 | 44 | 2005 |
